Literature DB >> 19495765

[Modern therapy concepts for endometrial cancer].

G Emons1, M Hellriegel, T Hawighorst.   

Abstract

Most cases of endometrial cancer (EC) become symptomatic at an early stage and have a good prognosis. EC has been traditionally treated with total abdominal hysterectomy plus bilateral salpingo-oophorectomy. For early stage, low grade cases (endometrioid, pT1a, pT1b; G1, G2) this is adequate therapy. For higher stages and grades, especially for type II EC (serous, clear cell) this therapy is insufficient. The efficacy of systematic pelvic and paraaortic lymphadenectomy for high risk EC, however, remains to be evaluated. External pelvic radiotherapy has been shown to improve local control in stage I and II EC, but has no positive effect on survival. A comparable improvement of local control can be achieved by vaginal brachytherapy with significantly less toxicity. Adjuvant chemotherapy is probably efficacious in EC. Its usefulness as exclusive adjuvant therapy or in combination with brachytherapy and/or external beam therapy remains to be evaluated by prospective trials.

Entities:  

Mesh:

Year:  2009        PMID: 19495765     DOI: 10.1007/s00292-009-1149-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases.

Authors:  M Signorelli; G Caspani; C Bonazzi; V Chiappa; P Perego; C Mangioni
Journal:  BJOG       Date:  2009-01       Impact factor: 6.531

2.  External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.

Authors:  Lilie L Lin; David G Mutch; Janet S Rader; Matthew A Powell; Perry W Grigsby
Journal:  Gynecol Oncol       Date:  2007-05-07       Impact factor: 5.482

3.  The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

Authors:  John K Chan; Huahsi Wu; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Daniel S Kapp
Journal:  Gynecol Oncol       Date:  2007-08       Impact factor: 5.482

4.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 5.  Endometrial cancer.

Authors:  V Hanf; A R Günthert; G Emons
Journal:  Onkologie       Date:  2003-10

Review 6.  Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs).

Authors:  Stefano Palomba; Angela Falbo; Rita Mocciaro; Tiziana Russo; Fulvio Zullo
Journal:  Gynecol Oncol       Date:  2008-10-29       Impact factor: 5.482

Review 7.  Adjuvant radiotherapy for stage I endometrial cancer.

Authors:  A Kong; N Johnson; P Cornes; I Simera; M Collingwood; C Williams; H Kitchener
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

8.  Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

Authors:  D C Smith; O K Macdonald; C M Lee; D K Gaffney
Journal:  Int J Gynecol Cancer       Date:  2007-07-11       Impact factor: 3.437

9.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  1 in total

Review 1.  Current therapy of patients with endometrial carcinoma. A critical review.

Authors:  S Marnitz; C Köhler
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.